ORAL CANCER: LYMPHO DISSECTION AT CN0 AND CN+ von Sh. I. Musin

Volltext

PERIOPERATIVE ASSESSMENT OF CHEMILUMINESCENCE INDICATORS OF LYMPH NODES IN TONGUE CANCER von Sh. I. Musin, R. R. Farkhutdinov

Volltext

Predictors of Multiple Primary Malignancies: Literature Review von A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva

Volltext

Features of the Course of Radioinduced Breast Cancer. Clinical Observation von M. M. Zamilov, K. V. Menshikov, Sh. I. Musin, A. V. Sultanbaev, G. I. Zamilova, A. H. Nguyen

Volltext

Hedgehog inhibitor in the treatment of basal cell skin cancer: case report von Sh. I. Musin, N. А. Sharafutdinova, A. V. Sultanbaev, S. V. Osokin, B. A. Ibragimov, K. V. Menshikov, R. T. Ayupov

Volltext

Clinical case of the treatment of metastatic luminal breast cancer von A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov

Volltext

A biopsy of the signaling lymph node in case of early oral cancer (cT1–2N0M0) by the lymphoscintigraphic method: one center study von Sh. I. Musin, S. V. Osokin, Т. G. Yatsenko, A. V. Sultanbaev, М. М. Zamilov, М. М. Vakhito, V. V. Ilyin

Volltext

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice von A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov

Volltext

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer von A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev

Volltext

Neuroendocrine Tumours: a Literature Review von K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov

Volltext

Combined Use of Cabozantinib and Nivolumab in Clinical Practice von V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova

Volltext

Metastatic renal cell carcinoma, the possibility of targeted therapy. Case. von K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov

Volltext

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency von R. T. Ayupov, A. A. Izmailov, K. V. Menshikov, A. V. Sultanbaev, A. F. Nasretdinov, R. R. Rakhimov, Sh. I. Musin, N. I. Sultanbaeva

Volltext

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) von K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Volltext

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review von K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, L. A. Khammatova

Volltext

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice von G. A. Serebrennikov, К. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov, A. Sh. Rezyapova

Volltext

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review von K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova

Volltext

Efficacy of the 1^st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens von K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov

Volltext

Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results von Sh. I. Musin, A. V. Sultanbayev, K. V. Menshikov, F. F. Mufazalov, A. F. Nasretdinov, O. V. Goncharova, S. V. Osokin, M. M. Zamilov, K. E. Timin

Volltext

Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case von A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva

Volltext